We are live on
!
Find out more
VI
Vestcor Inc Portfolio holdings
AUM
$3.63B
1-Year Est. Return
21.49%
This Fund
S&P 500
This Quarter
Est. Return
+1.29%
1 Year Est. Return
+21.49%
3 Year Est. Return
+77.59%
5 Year Est. Return
+109.03%
10 Year Est. Return
–
AUM
$3.63B
AUM Growth
+$123M
(+3.5%)
Cap. Flow
+$186M
Cap. Flow
% of AUM
5.11%
Top 10 Holdings %
Top 10 Hldgs %
18.05%
Holding
1,319
New
163
Increased
386
Reduced
255
Closed
127
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$52.5M |
| 2 |
Duke Energy
DUK
|
+$11.9M |
| 3 |
Cognizant
CTSH
|
+$10.8M |
| 4 |
Realty Income
O
|
+$9.5M |
| 5 |
Cencora
COR
|
+$8.86M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$18.5M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$17.2M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$14.4M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$14.2M |
| 5 |
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
|
+$9.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 10.61% |
| 3 | Financials | 9.99% |
| 4 | Real Estate | 9.52% |
| 5 | Communication Services | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Empire State Realty Trust
ESRT
$976M
| $147K | ﹤0.01% |
+28,320
| New | +$170K |
|
1077
Innoviva
INVA
$1.58B
| $147K | ﹤0.01% |
6,309
| – | – |
|
|
WSR
1078
DELISTED
Whitestone REIT
WSR
| $146K | ﹤0.01% |
+9,039
| New | +$136K |
|
1079
Andersons Inc
ANDE
$2.65B
| $145K | ﹤0.01% |
+2,021
| New | +$130K |
|
1080
Hyatt Hotels
H
$17.6B
| $145K | ﹤0.01% |
1,006
| – | – |
|
|
OPLN
1081
Openlane
OPLN
$4.17B
| $144K | ﹤0.01% |
4,956
| – | – |
|
1082
BioNTech
BNTX
$22.6B
| $143K | ﹤0.01% |
1,606
+1
| +0.1% | +$103 |
|
1083
Federal Signal
FSS
$7.25B
| $142K | ﹤0.01% |
1,312
-4,056
| -76% | -$458K |
|
1084
ePlus
PLUS
$2.33B
| $142K | ﹤0.01% |
1,886
| – | – |
|
1085
Toro Company
TTC
$8.93B
| $142K | ﹤0.01% |
1,515
-5,563
| -79% | -$524K |
|
1086
Tetra Tech
TTEK
$8.23B
| $142K | ﹤0.01% |
+4,699
| New | +$166K |
|
1087
Arrowhead Research
ARWR
$12.1B
| $140K | ﹤0.01% |
+2,234
| New | +$141K |
|
1088
World Acceptance Corp
WRLD
$950M
| $140K | ﹤0.01% |
1,036
| – | – |
|
1089
Core Laboratories
CLB
$538M
| $137K | ﹤0.01% |
8,140
| – | – |
|
1090
Murphy USA
MUSA
$11.3B
| $137K | ﹤0.01% |
277
-1,295
| -82% | -$555K |
|
1091
Franklin Electric
FELE
$4.67B
| $135K | ﹤0.01% |
1,464
| – | – |
|
1092
Molina Healthcare
MOH
$10.3B
| $134K | ﹤0.01% |
1,003
| – | – |
|
1093
TriNet
TNET
$2.84B
| $133K | ﹤0.01% |
3,640
| – | – |
|
1094
Moog Inc Class A
MOG.A
$13B
| $131K | ﹤0.01% |
+447
| New | +$137K |
|
1095
NewAmsterdam Pharma Warrant
NAMSW
| $131K | ﹤0.01% |
6,666
-2,966
| -31% | -$61.7K |
|
1096
CNX Resources
CNX
$4.85B
| $130K | ﹤0.01% |
3,373
| – | – |
|
1097
Grab
GRAB
$13.5B
| $130K | ﹤0.01% |
35,644
| – | – |
|
1098
Kforce
KFRC
$983M
| $130K | ﹤0.01% |
4,461
| – | – |
|
1099
BrightSpring Health Services
BTSG
$14.3B
| $129K | ﹤0.01% |
+3,034
| New | +$122K |
|
1100
Lindsay Corp
LNN
$1.16B
| $128K | ﹤0.01% |
1,076
| – | – |
|
Similar funds
JFG
GCM
ACM
APP
SCM
OCM
WB
SL
Vestcor Inc's Q1 2026 Portfolio in Review
As of Q1 2026, Vestcor Inc held 1,319 positions worth $3.63B, up 3.5% from $3.51B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Vestcor Inc deployed $186M of net new capital in Q1 2026, opening 163 new positions and adding to 386 existing holdings. Its largest new stake was Revolution Medicines: 63,077 shares worth $6.13M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $18.5M trimmed.
- Vestcor Inc's largest Q1 2026 buy was Revolution Medicines: 63,077 shares worth $6.13M.
- Vestcor Inc added most to iShares Core MSCI Emerging Markets ETF in Q1 2026, an estimated $52.5M increase.
- Vestcor Inc's biggest Q1 2026 reduction was Bristol-Myers Squibb, cutting an estimated $18.5M.
- Vestcor Inc fully exited Avidity Biosciences in Q1 2026, selling an estimated $14.4M.
- Vestcor Inc's ten largest holdings make up 18% of its $3.63B portfolio in Q1 2026.
- Vestcor Inc opened 163 new positions and closed 127 in Q1 2026.
- Vestcor Inc's portfolio value rose 3.5% quarter-over-quarter to $3.63B.
Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.